A Phase II Study of Proton Re-Irradiation Therapy for Recurrent Head and Neck Cancer


Full Title

A Phase II Study of Proton Re-Irradiation for Recurrent Head and Neck Cancer


Conventional “photon” radiation therapy is a common component of treatment for head and neck cancers. When the cancer comes back, however, giving more radiation could damage normal tissues that were already exposed to radiation the first time.

In this study, researchers are assessing the safety and effectiveness of giving proton therapy to patients whose head and neck cancer returned after prior photon radiation therapy. Proton therapy differs from photon therapy because the proton particles can stop shortly after passing through a tumor, and may therefore cause less damage to nearby healthy tissues than photon radiation therapy.


To be eligible for this study, patients must meet several criteria, including but not limited to the following:

  • Patients must have recurrent head and neck cancer that was previously treated with radiation therapy.
  • This study is for patients age 18 and older.

For more information about this study and to inquire about eligibility, please contact Dr. Nancy Lee at 212-639-3341.





Disease Status

Newly Diagnosed & Relapsed/Refractory